Melanoma Staging: Evidence-Based Changes in the American Joint Committee on Cancer Eighth Edition Cancer Staging Manual

By J. Gershenwald, R. Scolyer, K. Hess, V. Sondak, Georgina V. Long, M. Ross, A. Lazar, M. Faries, J. Kirkwood, G. McArthur and 5 more. Ca, 2017

2,184 citations recorded by the source corpus.

Answer questions and earn CME/CNE

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Neoadjuvant checkpoint blockade for cancer immunotherapy (2020, background): “Funding: We gratefully acknowledge research support from NCI R01 CA142779 (to S.L.T., J.M.T., and D.M.P.), the Cancer Research Institute/Stand Up To Cancer-Immunology Translational Cancer Research Grant AACR-DT1012 (to D.M.P.), Bristol-Myers Squibb (S.L.T., J.M.T., and D.M.P.), the Barney Family Fou”
Deep Adversarial Training for Multi-Organ Nuclei Segmentation in Histopathology Images (2018, background): “interior of the body, while the identification of cytological penetration of characteristic epithelial layers by cancer such as melanoma can drastically alter treatment course and prognosis [13].”
Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. (2019, background): “Indeed, the risk of relapse for SN-negative pT3b, pT4a and pT4b melanoma is quite high, with a mortality of about 20% at 10-year follow-up [12].”